US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist

4.950
+0.100+2.06%

Close May 13 16:00 ET

250.03MMarket Cap-1972P/E (TTM)

Monte Rosa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-63.06%-38.17M

52.63%-43.8M

223.68%29.63M

-19.93%-24.71M

-23.53%-25.32M

14.59%-23.41M

-55.76%-92.47M

-69.07%-23.96M

-15.77%-20.6M

-50.94%-20.5M

Net income from continuing operations

0.22%-31.97M

-24.75%-135.35M

-8.02%-33.25M

-27.70%-34.88M

-32.90%-35.18M

-33.87%-32.04M

-46.71%-108.5M

-31.32%-30.78M

-37.71%-27.32M

-43.81%-26.47M

Operating gains losses

----

198.17%107K

--0

---24K

204.80%131K

-741.18%-109K

--0

--16K

--0

Depreciation and amortization

64.81%1.9M

66.14%6.22M

72.52%1.85M

77.54%1.83M

56.47%1.39M

52.86%1.15M

75.66%3.75M

32.26%1.07M

77.49%1.03M

90.36%889K

Other non cash items

----

401.46%4.81M

--1.61M

--1.54M

--1.28M

Change In working capital

-377.85%-12.9M

3,495.78%72.47M

2,683.55%57.7M

245.42%4.37M

374.26%5.75M

169.44%4.64M

-133.95%-2.13M

-68.59%2.07M

302.56%1.27M

-63.68%1.21M

-Change in receivables

-100.49%-10K

1,114.44%1.9M

-3,260.00%-336K

311.86%375K

---195K

--2.05M

---187K

---10K

---177K

--0

-Change in prepaid assets

-73.26%-2.29M

150.63%1.08M

15,400.00%765K

83.61%-235K

2,433.75%1.87M

-117.11%-1.32M

-202.13%-2.13M

-100.56%-5K

36.44%-1.43M

-103.91%-80K

-Change in payables and accrued expense

-200.64%-8.96M

3,145.64%9.32M

216.88%7.06M

23.94%3.47M

76.30%1.76M

48.13%-2.98M

-95.12%287K

-51.60%2.23M

71.86%2.8M

-22.66%1M

-Change in other working capital

-123.88%-1.65M

56,340.19%60.18M

36,227.34%50.22M

925.68%759K

692.12%2.31M

2,162.28%6.89M

-109.65%-107K

---139K

--74K

--292K

Cash from discontinued investing activities

Operating cash flow

-63.06%-38.17M

52.63%-43.8M

223.68%29.63M

-19.93%-24.71M

-23.53%-25.32M

14.59%-23.41M

-55.76%-92.47M

-69.07%-23.96M

-15.77%-20.6M

-50.94%-20.5M

Investing cash flow

Cash flow from continuing investing activities

-51.53%9.85M

140.51%88.8M

126.51%14.3M

20.82%35.63M

230.18%18.55M

111.26%20.33M

-2,170.99%-219.22M

-1,670.23%-53.94M

1,846.98%29.49M

-427.55%-14.25M

Net PPE purchase and sale

84.93%-1.38M

-48.25%-18.98M

76.77%-1.69M

-17.16%-1.66M

-152.64%-6.45M

-487.77%-9.18M

-32.62%-12.8M

-138.63%-7.27M

16.11%-1.42M

5.48%-2.55M

Net investment purchase and sale

-61.92%11.24M

152.21%107.78M

134.25%15.99M

20.65%37.29M

313.75%25M

116.49%29.51M

---206.42M

---46.67M

--30.91M

---11.7M

Cash from discontinued investing activities

Investing cash flow

-51.53%9.85M

140.51%88.8M

126.51%14.3M

20.82%35.63M

230.18%18.55M

111.26%20.33M

-2,170.99%-219.22M

-1,670.23%-53.94M

1,846.98%29.49M

-427.55%-14.25M

Financing cash flow

Cash flow from continuing financing activities

1,266.67%246K

34.33%27.49M

23.19%25.17M

607.37%1.1M

1,150.00%1.2M

-88.24%18K

-94.58%20.47M

15,236.30%20.43M

-100.74%-217K

-99.95%96K

Net common stock issuance

----

--0

----

-91.56%20.06M

----

Proceeds from stock option exercised by employees

1,266.67%246K

3,462.32%27.61M

5,557.49%25.29M

1,293.67%1.1M

1,150.00%1.2M

-88.24%18K

420.13%775K

2,028.57%447K

--79K

-25.00%96K

Net other financing activities

----

68.13%-116K

----

89.09%-364K

56.41%-68K

----

Cash from discontinued financing activities

Financing cash flow

1,266.67%246K

34.33%27.49M

23.19%25.17M

607.37%1.1M

1,150.00%1.2M

-88.24%18K

-94.58%20.47M

15,236.30%20.43M

-100.74%-217K

-99.95%96K

Net cash flow

Beginning cash position

120.44%132.68M

-82.87%60.19M

-45.96%63.58M

-52.70%51.55M

-60.23%57.13M

-82.87%60.19M

719.84%351.41M

-68.09%117.66M

-69.62%108.98M

-15.31%143.64M

Current changes in cash

-816.59%-28.07M

124.89%72.49M

220.25%69.1M

38.64%12.02M

83.92%-5.57M

98.53%-3.06M

-194.38%-291.22M

-231.14%-57.47M

-13.05%8.67M

-118.32%-34.65M

End cash Position

83.12%104.62M

120.44%132.68M

-45.96%63.58M

-52.70%51.55M

-60.23%57.13M

-82.87%60.19M

-68.09%117.66M

-69.62%108.98M

Free cash flow

-21.36%-39.55M

40.36%-62.84M

189.48%27.95M

-19.84%-26.37M

-38.09%-31.84M

-12.02%-32.59M

-52.51%-105.38M

-81.25%-31.23M

-12.54%-22M

-41.58%-23.05M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-63.06%-38.17M	52.63%-43.8M	223.68%29.63M	-19.93%-24.71M	-23.53%-25.32M	14.59%-23.41M	-55.76%-92.47M	-69.07%-23.96M	-15.77%-20.6M	-50.94%-20.5M
Net income from continuing operations	0.22%-31.97M	-24.75%-135.35M	-8.02%-33.25M	-27.70%-34.88M	-32.90%-35.18M	-33.87%-32.04M	-46.71%-108.5M	-31.32%-30.78M	-37.71%-27.32M	-43.81%-26.47M
Operating gains losses	----	198.17%107K	--0	--0	---24K	204.80%131K	-741.18%-109K	--0	--16K	--0
Depreciation and amortization	64.81%1.9M	66.14%6.22M	72.52%1.85M	77.54%1.83M	56.47%1.39M	52.86%1.15M	75.66%3.75M	32.26%1.07M	77.49%1.03M	90.36%889K
Other non cash items	----	----	----	----	----	----	401.46%4.81M	--1.61M	--1.54M	--1.28M
Change In working capital	-377.85%-12.9M	3,495.78%72.47M	2,683.55%57.7M	245.42%4.37M	374.26%5.75M	169.44%4.64M	-133.95%-2.13M	-68.59%2.07M	302.56%1.27M	-63.68%1.21M
-Change in receivables	-100.49%-10K	1,114.44%1.9M	-3,260.00%-336K	311.86%375K	---195K	--2.05M	---187K	---10K	---177K	--0
-Change in prepaid assets	-73.26%-2.29M	150.63%1.08M	15,400.00%765K	83.61%-235K	2,433.75%1.87M	-117.11%-1.32M	-202.13%-2.13M	-100.56%-5K	36.44%-1.43M	-103.91%-80K
-Change in payables and accrued expense	-200.64%-8.96M	3,145.64%9.32M	216.88%7.06M	23.94%3.47M	76.30%1.76M	48.13%-2.98M	-95.12%287K	-51.60%2.23M	71.86%2.8M	-22.66%1M
-Change in other working capital	-123.88%-1.65M	56,340.19%60.18M	36,227.34%50.22M	925.68%759K	692.12%2.31M	2,162.28%6.89M	-109.65%-107K	---139K	--74K	--292K
Cash from discontinued investing activities
Operating cash flow	-63.06%-38.17M	52.63%-43.8M	223.68%29.63M	-19.93%-24.71M	-23.53%-25.32M	14.59%-23.41M	-55.76%-92.47M	-69.07%-23.96M	-15.77%-20.6M	-50.94%-20.5M
Investing cash flow
Cash flow from continuing investing activities	-51.53%9.85M	140.51%88.8M	126.51%14.3M	20.82%35.63M	230.18%18.55M	111.26%20.33M	-2,170.99%-219.22M	-1,670.23%-53.94M	1,846.98%29.49M	-427.55%-14.25M
Net PPE purchase and sale	84.93%-1.38M	-48.25%-18.98M	76.77%-1.69M	-17.16%-1.66M	-152.64%-6.45M	-487.77%-9.18M	-32.62%-12.8M	-138.63%-7.27M	16.11%-1.42M	5.48%-2.55M
Net investment purchase and sale	-61.92%11.24M	152.21%107.78M	134.25%15.99M	20.65%37.29M	313.75%25M	116.49%29.51M	---206.42M	---46.67M	--30.91M	---11.7M
Cash from discontinued investing activities
Investing cash flow	-51.53%9.85M	140.51%88.8M	126.51%14.3M	20.82%35.63M	230.18%18.55M	111.26%20.33M	-2,170.99%-219.22M	-1,670.23%-53.94M	1,846.98%29.49M	-427.55%-14.25M
Financing cash flow
Cash flow from continuing financing activities	1,266.67%246K	34.33%27.49M	23.19%25.17M	607.37%1.1M	1,150.00%1.2M	-88.24%18K	-94.58%20.47M	15,236.30%20.43M	-100.74%-217K	-99.95%96K
Net common stock issuance	----	--0	----	----	----	----	-91.56%20.06M	----	----	----
Proceeds from stock option exercised by employees	1,266.67%246K	3,462.32%27.61M	5,557.49%25.29M	1,293.67%1.1M	1,150.00%1.2M	-88.24%18K	420.13%775K	2,028.57%447K	--79K	-25.00%96K
Net other financing activities	----	68.13%-116K	----	----	----	----	89.09%-364K	56.41%-68K	----	----
Cash from discontinued financing activities
Financing cash flow	1,266.67%246K	34.33%27.49M	23.19%25.17M	607.37%1.1M	1,150.00%1.2M	-88.24%18K	-94.58%20.47M	15,236.30%20.43M	-100.74%-217K	-99.95%96K
Net cash flow
Beginning cash position	120.44%132.68M	-82.87%60.19M	-45.96%63.58M	-52.70%51.55M	-60.23%57.13M	-82.87%60.19M	719.84%351.41M	-68.09%117.66M	-69.62%108.98M	-15.31%143.64M
Current changes in cash	-816.59%-28.07M	124.89%72.49M	220.25%69.1M	38.64%12.02M	83.92%-5.57M	98.53%-3.06M	-194.38%-291.22M	-231.14%-57.47M	-13.05%8.67M	-118.32%-34.65M
End cash Position	83.12%104.62M	120.44%132.68M	120.44%132.68M	-45.96%63.58M	-52.70%51.55M	-60.23%57.13M	-82.87%60.19M	-82.87%60.19M	-68.09%117.66M	-69.62%108.98M
Free cash flow	-21.36%-39.55M	40.36%-62.84M	189.48%27.95M	-19.84%-26.37M	-38.09%-31.84M	-12.02%-32.59M	-52.51%-105.38M	-81.25%-31.23M	-12.54%-22M	-41.58%-23.05M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall